-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belimumab in Emphysema
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belimumab in Emphysema report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belimumab in Emphysema Drug Details: Belimumab (Benlysta) is a human IgG1 monoclonal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belimumab in Systemic Sclerosis (Scleroderma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belimumab in Systemic Sclerosis (Scleroderma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belimumab in Systemic Sclerosis (Scleroderma) Drug Details: Belimumab (Benlysta) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPL-044 in Epilepsy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPL-044 in Epilepsy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPL-044 in Epilepsy Drug Details: OPL-044 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPL-053 in Insomnia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPL-053 in Insomnia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPL-053 in Insomnia Drug Details: OPL-053 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – OPL-015 in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPL-015 in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPL-015 in Pain Drug Details: OPL-015 is under development for the treatment of...
-
Sector Analysis
Macau Insurance Industry – Key Trends and Opportunities to 2028
Macau Insurance Market Report Overview The gross written premium of the Macau insurance market was MOP38.4 billion ($4.9 billion) in 2023. The market is expected to achieve a CAGR of more than 5% during 2024-2028. The Macau insurance market research report provides in-depth market analysis, information, and insights into the Macau insurance industry. It provides a detailed outlook by product category as well as values for key performance indicators such as gross written premium, penetration, premium accepted and ceded, profitability...
-
Sector Analysis
United Kingdom (UK) Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
United Kingdom (UK) Construction Market Report Overview The UK construction market size was $509.3 billion in 2023. The market will achieve an AAGR of more than 2% during 2025-2028 supported by investments in renewable energy, industrial, and infrastructure projects. UK Construction Market Outlook, 2023-2028 ($ Billion) Buy the Full Report to Know More about the UK Construction Market Forecast Download a Free Report Sample The UK construction market research report gives a comprehensive understanding of project types and construction activities...
-
Sector Analysis
New Zealand Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
New Zealand Construction Market Report Overview The New Zealand construction market size was $56.3 billion in 2023. The market will achieve an AAGR of 3% during 2025-2028. The growth is attributed to the rising investment in transport, energy, housing, health, and education infrastructure projects. New Zealand Construction Market Outlook, 2023-2028 ($ Billion) Buy the Full Report to Know More about the New Zealand Construction Market Forecast Download a Free Report Sample The New Zealand construction market research report offers a...
-
Sector Analysis
Ireland Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
Ireland Construction Market Report Overview The Ireland construction market size was $26.9 billion in 2023. The market will achieve an AAGR of more than 4% from 2025 to 2028. The growth is attributed to the increase of investments in transport, electricity, and housing infrastructure projects. Ireland Construction Market Outlook, 2023-2028 ($ Billion) Buy the Full Report to Know More about the Ireland Construction Market Forecast Download a Free Report Sample The Ireland construction market research report offers a comprehensive understanding...
-
Product Insights
Dysmenorrhea – Drugs In Development, 2023
Global Markets Direct’s, ‘Dysmenorrhea - Drugs In Development, 2023’, provides an overview of the Dysmenorrhea pipeline landscape. The report provides comprehensive information on the therapeutics under development for Dysmenorrhea, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...